Castle Biosciences, Inc.
General ticker "CSTL" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $643.4M (TTM average)
Castle Biosciences, Inc. follows the US Stock Market performance with the rate: 44.5%.
Estimated limits based on current volatility of 2.6%: low 23.96$, high 25.22$
Factors to consider:
- Total employees count: 761 (+24.8%) as of 2024
- Top business risk factors: Geopolitical risks, Economic downturns and volatility, Supply chain disruptions, Inflationary pressures, Regulatory and compliance
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [27.66$, 49.77$]
- 2026-12-31 to 2027-12-31 estimated range: [24.52$, 45.13$]
Financial Metrics affecting the CSTL estimates:
- Negative: with PPE of -264.8 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.18 <= 0.31
- Positive: Shareholder equity ratio, % of 81.39 > 64.25
- Positive: 0.07 < Operating cash flow per share per price, % of 5.59
- Positive: Inventory ratio change, % of 0.50 <= 0.80
- Positive: -14.24 < Investing cash flow per share per price, % of -5.24
Short-term CSTL quotes
Long-term CSTL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $219.79MM | $332.07MM | $344.23MM |
| Operating Expenses | $287.76MM | $323.40MM | $387.04MM |
| Operating Income | $-67.98MM | $8.67MM | $-42.81MM |
| Non-Operating Income | $10.61MM | $12.89MM | $13.30MM |
| Interest Expense | $0.01MM | $0.58MM | $0.09MM |
| R&D Expense | $53.62MM | $52.04MM | $51.85MM |
| Income(Loss) | $-57.37MM | $21.56MM | $-29.51MM |
| Taxes | $0.10MM | $3.32MM | $-5.36MM |
| Profit(Loss)* | $-57.47MM | $18.25MM | $-24.16MM |
| Stockholders Equity | $391.27MM | $455.83MM | $470.87MM |
| Inventory | $7.94MM | $8.13MM | $10.25MM |
| Assets | $453.34MM | $531.24MM | $578.56MM |
| Operating Cash Flow | $-5.63MM | $64.87MM | $64.35MM |
| Capital expenditure | $13.62MM | $28.33MM | $36.02MM |
| Investing Cash Flow | $-16.18MM | $-50.14MM | $-60.37MM |
| Financing Cash Flow | $-2.30MM | $6.14MM | $-6.96MM |
| Earnings Per Share** | $-2.14 | $0.66 | $-0.83 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.